Evidence map›Paper›PMID 33848402›Full record

ArticlePediatric pulmonology2021

Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic.

Lisa Ulrich, Charlie Macias, Ashish George, Shasha Bai, Elizabeth Allen

Abstract read
In one paragraph

Article in Pediatric pulmonology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Changes in asthma emergency department visits in the United States during the COVID-19 pandemic.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Article
  8. Review
  9. Article
  10. Reduced asthma morbidity during COVID-19 in minority children: is medication adherence a reason?The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Asthma as a risk factor for hospitalization in children with COVID-19: A nested case-control study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa UlrichSection of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID 0000-0002-7232-2442
Charlie MaciasQuality Improvement Services, Nationwide Children's Hospital, Columbus, Ohio, USA.
Ashish GeorgeSection of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID 0000-0002-2952-1884
Shasha BaiBiostatistics Resource at Nationwide Children's Hospital, Columbus, Ohio, USA.
Elizabeth AllenSection of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic profoundly impacted health care utilization. We evaluated asthma-related emergency department (ED) and inpatient health care utilization by a county-specific Medicaid population, ages 2-18, during the COVID-19 pandemic and compared it to utilization from a 3-year average including 2017-2019. All-cause ED utilization and asthma medication fill rates were evaluated during the same timeframes. Relative to the 2017-2019 3-year average, cumulative asthma-related ED visits from January through June decreased by 45.8% (p = .03) and inpatient admission rates decreased by 50.5% (p = .03). The decline in asthma-related ED utilization was greater than the reduction of overall ED use during the same time period, suggesting that the decline involved factors specific to asthma and was not due solely to avoidance of health care facilities. Fill rates for asthma controller medications decreased during this time (p = .03) and quick relief medication fill rates had no significant change (p = .31). Multiple factors may have contributed to the decrease in acute asthma health care visits. Locally, decreased air pollution and viral exposures coincided with the "Stay-at-home" order in Ohio, and increased utilization of telehealth for assessment during exacerbations may have impacted outcomes. Identification of the cause of the decline in visit rates could spur new interventions to limit the need for ED and inpatient visits for asthma patients, leading to both economic and health-associated benefits.

Indexed as

PandemicsAdolescentAir PollutionAsthmaChildChild, PreschoolCOVID-19Emergency Service, HospitalFemaleHumansInpatientsMaleMedicaidMorbidityOhioPatient Acceptance of Health Careasthmacoronavirushealth care utilizationpandemic

Identifiers

PMID33848402
PMCPMC8251009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.